Healthcare provider profile · identity verified

Brian J Dudor, MD

Family Practice · MUSKEGO, WI · NPI 1942388459

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	713	191
Losartan Potassium	Losartan Potassium	489	134
Amlodipine Besylate	Amlodipine Besylate	426	109
Lisinopril	Lisinopril	393	108
Metoprolol Succinate	Metoprolol Succinate	333	84
Metformin Hcl Er	Metformin Hcl	277	76
Simvastatin	Simvastatin	267	72
Levothyroxine Sodium	Levothyroxine Sodium	257	63
Pantoprazole Sodium	Pantoprazole Sodium	238	61
Gabapentin	Gabapentin	212	51
Hydrochlorothiazide	Hydrochlorothiazide	195	53
Tamsulosin Hcl	Tamsulosin Hcl	182	47
Escitalopram Oxalate	Escitalopram Oxalate	174	48
Omeprazole	Omeprazole	165	46
Albuterol Sulfate Hfa	Albuterol Sulfate	159	53
Furosemide	Furosemide	136	49
Atenolol	Atenolol	124	31
Rosuvastatin Calcium	Rosuvastatin Calcium	117	34
Glimepiride	Glimepiride	110	25
Allopurinol	Allopurinol	108	30
Metformin Hcl	Metformin Hcl	101	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	97	29
Metoprolol Tartrate	Metoprolol Tartrate	89	23
Eliquis	Apixaban	88	21
Warfarin Sodium	Warfarin Sodium	88	21
Potassium Chloride	Potassium Chloride	79	25
Alprazolam	Alprazolam	76	25
Tizanidine Hcl	Tizanidine Hcl	75	25
Zolpidem Tartrate	Zolpidem Tartrate	72	21
Jardiance	Empagliflozin	71	18
Spironolactone	Spironolactone	70	17
Alendronate Sodium	Alendronate Sodium	67	16
Fluticasone Propionate	Fluticasone Propionate	66	21
Trazodone Hcl	Trazodone Hcl	65	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	19
Tramadol Hcl	Tramadol Hcl	64	23
Carvedilol	Carvedilol	62	20
Clopidogrel	Clopidogrel Bisulfate	58	17
Pravastatin Sodium	Pravastatin Sodium	56	16
Finasteride	Finasteride	55	13
Sertraline Hcl	Sertraline Hcl	55	13
Clonazepam	Clonazepam	52	16
Montelukast Sodium	Montelukast Sodium	51	13
Meloxicam	Meloxicam	49	14
Celecoxib	Celecoxib	45	13
Synthroid	Levothyroxine Sodium	43	suppressed
Xarelto	Rivaroxaban	41	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Lovastatin	Lovastatin	34	11
Ezetimibe	Ezetimibe	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Lorazepam	Lorazepam	31	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Ozempic	Semaglutide	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Colchicine	Colchicine	25	suppressed
Valsartan	Valsartan	25	suppressed
Famotidine	Famotidine	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Amoxicillin	Amoxicillin	22	14
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Temazepam	Temazepam	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	16
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	12
Fenofibrate	Fenofibrate	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Ramipril	Ramipril	16	suppressed
Risperidone	Risperidone	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Invokana	Canagliflozin	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Prednisone	Prednisone	13	12
Rocklatan	Netarsudil Mesylat/Latanoprost	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Thioridazine Hcl	Thioridazine Hcl	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Digoxin	Digoxin	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error